Cargando…
Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
Frailty is a geriatric syndrome of impaired resistance to stressors due to a decline in physiologic reserve. Frailty and cardiovascular disease (CVD) share a common biological pathway, and CVD may accelerate the development of frailty. Frailty is identified in 25% to 50% of patients with CVD, depend...
Autor principal: | Afilalo, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165117/ https://www.ncbi.nlm.nih.gov/pubmed/21949560 http://dx.doi.org/10.1007/s12170-011-0186-0 |
Ejemplares similares
-
Frailty in patients admitted to hospital for acute coronary syndrome: when, how and why?
por: Tonet, Elisabetta, et al.
Publicado: (2019) -
Sarcopenia: how to measure, when and why
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2022) -
Not if but when; no longer why but how
por: Piper, Ian
Publicado: (2007) -
The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
por: Yu, Christopher, et al.
Publicado: (2021) -
Measure of sperm DNA fragmentation (SDF): how, why and when?
por: Amiri-Yekta, Amir, et al.
Publicado: (2017)